Cached score snapshot
US.HSIC · Henry Schein
110分制 45.3/110;5D動能v2 9/50;排序分 54.3/160 · Incomplete inputs
Score breakdown
避免
Score and price trend
Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.
Move the mouse over the chart lines to inspect readings.
- Main score
- 5D momentum v2
- Candlestick
- Historical projection
- Score turn
- Setup grade
| Model | Median | P25/P75 | 歷史相似情境上漲比例 | Down5 | Actual / compare |
|---|---|---|---|---|---|
| Rolling DOE best | +0.18% | -1.58% / +3.99% | 52.5% | 3.8% | Actual outcome pending · 0 / 3 bars observed |
| 30D observation | +7.38% | -0.66% / +14.21% | 71.3% | 6.3% | Actual outcome pending · 0 / 30 bars observed |
| Historical projection 10D n=160 | +0.38% | -1.37% / +3.36% | 53.1% | 3.8% | Actual outcome pending · 0 / 10 bars observed |
歷史情境統計基於已存檔相似 setup;圖中投影中位線為統計中位數的線性插值展示,並非價格路徑預測或買賣建議。
2026-06-22 → 2026-10-27 · 90 archived points · 5 Deteriorating signal
Summary
score_with_momentum_v2 = main score + 5D momentum v2
Rolling setup rating
Setup quality, historical edge, and risk are combined into a rolling S/A/B/C/D/F grade for this snapshot date.
Score turn monitor
Has the score quality changed?
Run more market refreshes to build enough archived points for a turn check.
Signals
技術信號 16.9 · 風險管理 7.4 · 5D動能v2 9 · Incomplete inputs
INSTITUTIONAL_DATA_OPTIONAL: Institutional ownership unavailable; neutral money-flow treatment used. FMP_INSTITUTIONAL_FAILED: FMP HTTP 402
Audit trace
Full calculation detail
Calculation detail · 8 sections
Incomplete score
此 snapshot 已計出評分,但以下輸入仍不完整;缺失維度以 0 分處理,請留意 audit 明细。
- VIX_MISSING: VIX market context is required for market environment scoring
Market inputs
Metrics snapshot
110-point main rating
基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10
基本面 — 2.2/5 · 較差
Sub-items
資金流 — 5.2/20 · 較差
Sub-items
institutional
details
warning
市場環境 — 5.6/15 · 較差
Sub-items
vix
details
trend
details
qqq
spy
催化劑 — 2/20 · 較差
Sub-items
catalyst
details
風險管理 — 7.4/10 · 良好
Sub-items
position
details
stopLevels
strength_details
diversification
details
技術信號 — 16.9/30 · 較差
Sub-items
vcpPayload
vcp_metrics
情緒分析 — 6/10 · 一般
Sub-items
sentiment
details
sentimentData
Dimension contribution
5D momentum v2 breakdown
Cursor_18.25 5D momentum v2 0-50
Risk management
position
details
stopLevels
strength_details
diversification
details
Calculation audit log
基本面分析總分: 2.2/5分 資金流分析總分: 5.2/20分 市場環境分析總分: 5.6/15分 催化劑分析: 2/20分 風險管理總分: 7.4/10分 技術信號分析總分: 16.9/30分 情緒分析: 6/10分 共振率(僅顯示不加分): 0%
Technical indicators
adx
atr
cci
cmf
kdj
mfi
obv
rsi
sar
ma50
macd
vwap
volume
derived
ma_cross
bollinger
rsi_short
macd_short
volume_ratio
Raw calculation JSON
{
"risk": {
"level": "Medium",
"reason": "risk management score >= 6.5/10",
"position": {
"score": 1.6,
"details": {
"atrPct": 1.8803702010968921,
"turnoverUsdM": 126.07457296,
"liquidityPoints": 0.4,
"volatilityPoints": 1.2
}
},
"rrPoints": 1.4,
"stopLevels": {
"symbol": "US.HSIC",
"rr_range": "1:1.0-1:2.5",
"risk_profile": "中等",
"stop_loss_price": 84.2286,
"strength_details": {
"ma_score": 2,
"atr_score": 2.5,
"rsi_score": 1,
"macd_score": 1.5,
"volume_score": 2
},
"market_adjustment": 1,
"risk_reward_ratio": 1.3,
"stop_loss_percent": 3.8,
"take_profit_price": 91.896,
"target_multiplier": 1.9,
"technical_strength": 1.75,
"take_profit_percent": 5
},
"positionPoints": 1.6,
"stopLossPoints": 2.4,
"diversification": {
"score": 2,
"details": {
"method": "sector concentration proxy; no portfolio holdings used",
"sector": "Health Care",
"concentratedSectorPenalty": 0
}
},
"riskRewardRatio": 1.3295254299082457,
"stopLossPercent": 3.7607404021937842,
"diversificationPoints": 2
},
"total": {
"max": 160,
"result": 54.3,
"formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
"baseScore": 45.3,
"modelVersion": "cursor_18_27_news_v2_160",
"momentum5dScore": 9
},
"market": {
"ma20": 89.157,
"ma50": 87.8064,
"close": 87.52,
"prevClose": 88.93,
"avgVolume20": 894241,
"volumeRatio": 1.61,
"changePercent": -1.59
},
"sources": {
"catalyst": "finnhub_news_keyword_model",
"sentiment": "finnhub_news_keyword_model",
"fundamentals": "fmp_stable",
"institutional": null,
"marketContext": "twelvedata+fred"
},
"barCount": 60,
"momentum": {
"max": 50,
"result": 9,
"details": {
"ret_5d": -0.01507990096781453,
"max_score": 50,
"max_total": 50,
"raw_total": 9,
"vcp_bonus": 0,
"vol_ratio": 1.626781328168672,
"ret_points": 0,
"vol_points": 6,
"range_ratio": 1.0724318876856411,
"volat_points": 0,
"day_range_pct": 0.019081352833638047,
"model_version": "cursor_18_27_news_v2_160",
"available_bars": 30,
"breakout_points": 0,
"partial_history": false,
"pullback_points": 3,
"breakout_vol_bonus": 0,
"first_breakout_20d": false,
"return_window_days": 5,
"first_breakout_bonus": 0,
"breakout_quality_points": 0
},
"formula": "Cursor_18.25 5D momentum v2 0-50",
"modelVersion": "cursor_18_27_news_v2_160"
},
"scoreMax": 110,
"composite": {
"max": 160,
"result": 54.3,
"formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
"weights": [
{
"raw": 2.2,
"label": "基本面",
"weight": "5/110",
"normalized": 44,
"contribution": 2.2
},
{
"raw": 5.2,
"label": "資金流",
"weight": "20/110",
"normalized": 26,
"contribution": 5.2
},
{
"raw": 5.6,
"label": "市場環境",
"weight": "15/110",
"normalized": 37.33,
"contribution": 5.6
},
{
"raw": 2,
"label": "催化劑",
"weight": "20/110",
"normalized": 10,
"contribution": 2
},
{
"raw": 7.4,
"label": "風險管理",
"weight": "10/110",
"normalized": 74,
"contribution": 7.4
},
{
"raw": 16.9,
"label": "技術信號",
"weight": "30/110",
"normalized": 56.33,
"contribution": 16.9
},
{
"raw": 6,
"label": "情緒分析",
"weight": "10/110",
"normalized": 60,
"contribution": 6
}
],
"modelVersion": "cursor_18_27_news_v2_160"
},
"momentumMax": 50,
"scoreStatus": "incomplete",
"standard110": {
"rating": "避免",
"result": 45.3,
"details": [
"基本面分析總分: 2.2/5分",
"資金流分析總分: 5.2/20分",
"市場環境分析總分: 5.6/15分",
"催化劑分析: 2/20分",
"風險管理總分: 7.4/10分",
"技術信號分析總分: 16.9/30分",
"情緒分析: 6/10分",
"共振率(僅顯示不加分): 0%"
],
"formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
"dimensionScores": {
"催化劑": 2,
"基本面": 2.2,
"資金流": 5.2,
"市場環境": 5.6,
"情緒分析": 6,
"技術信號": 16.9,
"風險管理": 7.4
},
"dimensionDetails": {
"催化劑": {
"max": 20,
"grade": "較差",
"items": {
"catalyst": {
"score": 2,
"details": {
"source": "finnhub_news_keyword_model",
"articleCount": 8,
"catalystCount": 0
}
},
"catalystPoints": 2
}
},
"基本面": {
"max": 5,
"grade": "較差",
"items": {
"pbPoints": 0.4,
"pePoints": 0.2,
"epsPoints": 0,
"roePoints": 0.4,
"debtPoints": 0.4,
"marginPoints": 0,
"turnoverUsdM": 126.07457296,
"volumePoints": 0.5,
"revenuePoints": 0,
"dividendPoints": 0,
"marketCapPoints": 0.3
},
"source": "fmp_stable"
},
"資金流": {
"max": 20,
"grade": "較差",
"items": {
"cmfPoints": 0.8,
"mfiPoints": 0.8,
"obvPoints": 0.8,
"vwapPoints": 0.8,
"institutional": {
"score": 2,
"details": {
"source": "optional-neutral",
"warning": {
"code": "INSTITUTIONAL_DATA_OPTIONAL",
"symbol": "US.HSIC",
"message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
},
"optional": true,
"holderCount": null,
"holderPoints": 2,
"top10ShareRatio": null,
"concentrationPenalty": 0
}
},
"institutionPoints": 2
}
},
"市場環境": {
"max": 15,
"grade": "較差",
"items": {
"vix": {
"score": 0,
"details": {
"source": "twelvedata+fred",
"missing": true,
"vixClose": null
}
},
"trend": {
"score": 0.8,
"details": {
"qqq": {
"ma20": 713.30699735,
"ma50": 709.9723986999998,
"name": "QQQ",
"close": 704.53998,
"points": 0.4
},
"spy": {
"ma20": 765.34199445,
"ma50": 759.0606000200002,
"name": "SPY",
"close": 757.39001,
"points": 0.4
},
"source": "twelvedata+fred"
}
},
"atrPct": 1.8803702010968921,
"atrPoints": 4,
"cciPoints": 0.8,
"vixPoints": 0,
"marketTrendPoints": 0.8
}
},
"情緒分析": {
"max": 10,
"grade": "一般",
"items": {
"sentiment": {
"score": 6,
"details": {
"source": "finnhub_news_keyword_model",
"articleCount": 8,
"negativeHits": 0,
"positiveHits": 5,
"sentimentScoreRaw": 1.5
}
},
"sentimentData": {
"raw": [
{
"id": 142168846,
"url": "https://finnhub.io/api/news?id=b73614a2be6023b634b7e9c0be6c10d50d816494a10d0613f07803053835c8b3",
"image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"source": "SeekingAlpha",
"related": "HSIC",
"summary": "Henry Schein, Inc. (HSIC) 2026 Global Healthcare Conference September 15, 2026 12:15 PM EDTCompany ParticipantsFrederick Lowery - CEO & DirectorRonald...",
"category": "company",
"datetime": 1789495302,
"headline": "Henry Schein, Inc. (HSIC) Presents at 2026 Global Healthcare Conference Transcript"
},
{
"id": 141402175,
"url": "https://finnhub.io/api/news?id=d28896b719fe5f0f52c269eaee653031d986ee927ba0777ee23569a69473fa94",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Henry Schein (HSIC) could produce exceptional returns because of its solid growth attributes.",
"category": "company",
"datetime": 1788457502,
"headline": "Henry Schein (HSIC) is an Incredible Growth Stock: 3 Reasons Why"
},
{
"id": 141400688,
"url": "https://finnhub.io/api/news?id=687c6532284f70bdd17c063476cfe4435756111b20c1571fe712339206900205",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
"category": "company",
"datetime": 1788449414,
"headline": "Why Is Henry Schein (HSIC) Up 0.9% Since Last Earnings Report?"
},
{
"id": 141376742,
"url": "https://finnhub.io/api/news?id=6357db02e9beba73d4a317034c225b13d7068feb02e840788847e2ae69d50324",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
"category": "company",
"datetime": 1788360003,
"headline": "Is Henry Schein (HSIC) Stock Undervalued Right Now?"
},
{
"id": 141373305,
"url": "https://finnhub.io/api/news?id=9938a6ed856998287cea2992d204673e307eddab99bfdaf3d24d3141ba6cb2df",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Henry Schein stock performance snapshot Henry Schein (HSIC) stock has drawn investor attention after recent share price moves, with the company reporting positive total returns over the past year and across multi year periods, alongside reported revenue and net income growth. At the latest share price of US$88.52, Henry Schein has given investors a 16.9% share price return over the past 90 days and a 29.4% total shareholder return over the past year. This suggests momentum has been building...",
"category": "company",
"datetime": 1788307678,
"headline": "Henry Schein (HSIC) Looks Modestly Undervalued, Is More Upside Still Available?"
},
{
"id": 141365811,
"url": "https://finnhub.io/api/news?id=49d383c4145e42a1a0edc062dc4b916919c3a07f62db12935fc0baad823200ec",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "MD Sass, a boutique asset management firm, published its second-quarter investor update for its flagship, the “MD Sass Concentrated Value Strategy.” The letter can be downloaded here. In the first half of 2026, AI infrastructure stocks led the market, with the Russell 1000 Value increasing by 16.3%, outpacing the S&P 500 (10.2%) and Russell 1000 […]",
"category": "company",
"datetime": 1788192071,
"headline": "Growth Trajectory and Attractive Valuations Support Henry Schein’s (HSIC) Bullish Thesis"
},
{
"id": 141365810,
"url": "https://finnhub.io/api/news?id=ce62d2ef3d17289170a510a2b8b435138c1904f9174d48928d4218872d21e5cf",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "HSIC vs. SAUHY: Which Stock Is the Better Value Option?",
"category": "company",
"datetime": 1787676003,
"headline": "HSIC vs. SAUHY: Which Stock Is the Better Value Option?"
},
{
"id": 141279876,
"url": "https://finnhub.io/api/news?id=80e2683d6b03e9856102f88928d0b33f293bf6830fce12c7e49c75c925df79ae",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Henry Schein's broader growth, recurring technology revenues and savings plan support its outlook, but leverage and execution risks remain key concerns.",
"category": "company",
"datetime": 1787157180,
"headline": "Is HSIC Worth Buying as Growth Improves but Execution Risks Persist?"
}
],
"raw_source": [
{
"id": 142168846,
"url": "https://finnhub.io/api/news?id=b73614a2be6023b634b7e9c0be6c10d50d816494a10d0613f07803053835c8b3",
"image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"source": "SeekingAlpha",
"related": "HSIC",
"summary": "Henry Schein, Inc. (HSIC) 2026 Global Healthcare Conference September 15, 2026 12:15 PM EDTCompany ParticipantsFrederick Lowery - CEO & DirectorRonald...",
"category": "company",
"datetime": 1789495302,
"headline": "Henry Schein, Inc. (HSIC) Presents at 2026 Global Healthcare Conference Transcript"
},
{
"id": 142025001,
"url": "https://finnhub.io/api/news?id=1070370c1f7fc4038762bd87c7e362d43f788cbfea7cb41756a7b50cb0271c60",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "MIAMI, September 09, 2026--DermaSensor Inc., a leader in AI-powered skin cancer diagnostic technology, announced today the close of a $4M Series B extension, including institutional and strategic investors, alongside the launch of a community investment round on Wefunder. This new community financing has already raised more than $1 million at the same terms as the $4M. This follows the company’s $16M Series B, closed in 2025, and brings the total investment in the company to $48 million.",
"category": "company",
"datetime": 1788955200,
"headline": "DermaSensor Raises $5 Million and Opens Round to the Public via Wefunder, Alongside Four Major New US Partnerships"
},
{
"id": 141951354,
"url": "https://finnhub.io/api/news?id=41175e417bb8b6f5ac4faee49d7be467bc1d34d6ef96ded5758e72e5d91703f4",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "MELVILLE, N.Y., September 08, 2026--Henry Schein, Inc., the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that the Company will present at the following conference in September:",
"category": "company",
"datetime": 1788863400,
"headline": "Henry Schein to Participate in Upcoming Investor Conference in September"
},
{
"id": 141402175,
"url": "https://finnhub.io/api/news?id=d28896b719fe5f0f52c269eaee653031d986ee927ba0777ee23569a69473fa94",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Henry Schein (HSIC) could produce exceptional returns because of its solid growth attributes.",
"category": "company",
"datetime": 1788457502,
"headline": "Henry Schein (HSIC) is an Incredible Growth Stock: 3 Reasons Why"
},
{
"id": 141400688,
"url": "https://finnhub.io/api/news?id=687c6532284f70bdd17c063476cfe4435756111b20c1571fe712339206900205",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
"category": "company",
"datetime": 1788449414,
"headline": "Why Is Henry Schein (HSIC) Up 0.9% Since Last Earnings Report?"
},
{
"id": 141376742,
"url": "https://finnhub.io/api/news?id=6357db02e9beba73d4a317034c225b13d7068feb02e840788847e2ae69d50324",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
"category": "company",
"datetime": 1788360003,
"headline": "Is Henry Schein (HSIC) Stock Undervalued Right Now?"
},
{
"id": 141373305,
"url": "https://finnhub.io/api/news?id=9938a6ed856998287cea2992d204673e307eddab99bfdaf3d24d3141ba6cb2df",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Henry Schein stock performance snapshot Henry Schein (HSIC) stock has drawn investor attention after recent share price moves, with the company reporting positive total returns over the past year and across multi year periods, alongside reported revenue and net income growth. At the latest share price of US$88.52, Henry Schein has given investors a 16.9% share price return over the past 90 days and a 29.4% total shareholder return over the past year. This suggests momentum has been building...",
"category": "company",
"datetime": 1788307678,
"headline": "Henry Schein (HSIC) Looks Modestly Undervalued, Is More Upside Still Available?"
},
{
"id": 141365809,
"url": "https://finnhub.io/api/news?id=8e5a0c6b652b0428f6553ebc34b3d1ff1203175c6a5f0bf47c9e1080268b720e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "MIAMI, September 01, 2026--DermaSensor Inc., a leader in AI-powered skin cancer diagnostic technology, today announced a major expansion of its U.S. commercial strategy through a series of strategic partnerships to accelerate adoption of its FDA cleared, handheld skin cancer detection device across primary care, enterprise healthcare, and federal healthcare systems.",
"category": "company",
"datetime": 1788267600,
"headline": "DermaSensor Announces Four Major New Industry Partnerships to Accelerate Growth in the US"
},
{
"id": 141365811,
"url": "https://finnhub.io/api/news?id=49d383c4145e42a1a0edc062dc4b916919c3a07f62db12935fc0baad823200ec",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "MD Sass, a boutique asset management firm, published its second-quarter investor update for its flagship, the “MD Sass Concentrated Value Strategy.” The letter can be downloaded here. In the first half of 2026, AI infrastructure stocks led the market, with the Russell 1000 Value increasing by 16.3%, outpacing the S&P 500 (10.2%) and Russell 1000 […]",
"category": "company",
"datetime": 1788192071,
"headline": "Growth Trajectory and Attractive Valuations Support Henry Schein’s (HSIC) Bullish Thesis"
},
{
"id": 141365810,
"url": "https://finnhub.io/api/news?id=ce62d2ef3d17289170a510a2b8b435138c1904f9174d48928d4218872d21e5cf",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "HSIC vs. SAUHY: Which Stock Is the Better Value Option?",
"category": "company",
"datetime": 1787676003,
"headline": "HSIC vs. SAUHY: Which Stock Is the Better Value Option?"
},
{
"id": 141286284,
"url": "https://finnhub.io/api/news?id=151b5782cb14f4a0f7bfd3c361f221aae4b1703448ea92601538b7c34f01134b",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Henry Schein has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.",
"category": "company",
"datetime": 1787232090,
"headline": "What Are Wall Street Analysts' Target Price for Henry Schein Stock?"
},
{
"id": 141279876,
"url": "https://finnhub.io/api/news?id=80e2683d6b03e9856102f88928d0b33f293bf6830fce12c7e49c75c925df79ae",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Henry Schein's broader growth, recurring technology revenues and savings plan support its outlook, but leverage and execution risks remain key concerns.",
"category": "company",
"datetime": 1787157180,
"headline": "Is HSIC Worth Buying as Growth Improves but Execution Risks Persist?"
},
{
"id": 141253898,
"url": "https://finnhub.io/api/news?id=b3f895614765ccd454c0725a904f618cefbecf7a27eeb83209f5be75a57ddf15",
"image": "https://cdn.benzinga.com/files/images/story/2026/08/19/Palo-Alto-Networks-Inc.jpg?width=2048&height=1536",
"source": "Benzinga",
"related": "HSIC",
"summary": "Analysts changed outlook on top names. Piper Sandler raises Mercury Systems' target price, Ascendiant Capital boosts Alzamend Neuro's target price, BTIG raises Henry Schein's target price, Cantor Fitzgerald increases Palo Alto's target price, Morgan Stanley cuts Baidu's target price, Cantor Fitzgerald slashes Crowdstrike Holdings' target price, Baird raises Donaldson Company's target price, B of A Securities cuts Pony AI's target price.",
"category": "company",
"datetime": 1787127787,
"headline": "Palo Alto To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday"
},
{
"id": 141253899,
"url": "https://finnhub.io/api/news?id=c7eb1d87fe8af6c8b765c3aca595a56aa9a80cb1a846db318c265d0f4c67e0c4",
"image": "",
"source": "Benzinga",
"related": "HSIC",
"summary": "BTIG analyst David Larsen maintains Henry Schein (NASDAQ:HSIC) with a Buy and raises the price target from $100 to $110.",
"category": "company",
"datetime": 1787119816,
"headline": "BTIG Maintains Buy on Henry Schein, Raises Price Target to $110"
},
{
"id": 141286292,
"url": "https://finnhub.io/api/news?id=2a5fbd442fce46d34bbfc3370094fb2e462cf5b8fc898393172d5aaeb139dc49",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Henry Schein's stronger Q2 sales and margins prompt a 2026 outlook hike, but second-half savings execution remains key to sustaining earnings momentum.",
"category": "company",
"datetime": 1787061300,
"headline": "HSIC Raises 2026 Outlook as Sales and Margin Momentum Accelerates"
},
{
"id": 141284800,
"url": "https://finnhub.io/api/news?id=6b478d45dc2071f65f1034954c5f5d995decb992f26370a6fe61f0b84b0e2c9b",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.",
"category": "company",
"datetime": 1787046813,
"headline": "3 Unpopular Stocks with Open Questions"
},
{
"id": 141286042,
"url": "https://finnhub.io/api/news?id=80177f03e360ea268322086fc04b3cc7785df9b082c3b5ec4ec0597006971e08",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Align's $37.5M U.K. VAT liability, new 20% VAT charges and pending appeal add fresh earnings uncertainty amid currency and mix pressures.",
"category": "company",
"datetime": 1786981260,
"headline": "How the U.K. VAT Ruling Could Reshape Align's 2026 Earnings Outlook"
}
],
"data_source": "finnhub_news_keyword_model",
"article_count": 8,
"negative_hits": 0,
"positive_hits": 5,
"recomputed_at_score": true,
"sentiment_score_raw": 1.5,
"source_article_count": 17,
"discarded_article_count": 8
},
"sentimentPoints": 6
}
},
"技術信號": {
"max": 30,
"raw": 16.9,
"grade": "較差",
"items": {
"bbPoints": 2.4,
"adxPoints": 3,
"sarPoints": 1.2000000000000002,
"vcpPoints": 1,
"macdPoints": 2.4,
"vcpPayload": {
"vcp_pass": false,
"vcp_score": 1,
"vcp_reason": "跌縮量(近10日4日);靠近20日高位;Ready=N;Confirm=N",
"vcp_metrics": {
"up_days": 4,
"vol_ref": 1063556.6666666667,
"down_days": 5,
"vcp_ready": false,
"above_ma50": false,
"avg_vol_10": 884650,
"avg_vol_20": 885505,
"avg_vol_30": 1063556.6666666667,
"range_pct_10": 0.05233089579524678,
"range_pct_20": 0.05233089579524678,
"range_pct_30": 0.07369744058500918,
"up_expand_ok": false,
"lookback_used": 59,
"near_20d_high": true,
"contraction_ok": false,
"down_shrink_ok": true,
"up_expand_days": 0,
"breakout_20d_ok": false,
"vol_ratio_10_30": 0.83178454681932,
"dist_to_20d_high": 0.045479332533536934,
"down_shrink_days": 4,
"breakout_level_20d": 91.69,
"vcp_breakout_confirm": false,
"contraction_ratio_10_30": 0.7100775193798443
},
"vcp_name_en": "Volatility Contraction Pattern",
"vcp_name_zh": "波動收縮形態",
"vol_contraction": false
},
"kdjAdxPoints": 0.5,
"rsiKdjPoints": 2.4,
"volumeWeight": 2,
"maCrossPoints": 2.4,
"shortRsiPoints": 0,
"shortMacdPoints": 0.4,
"volConfirmPoints": 0,
"volumePointsTechnical": 1.2
}
},
"風險管理": {
"max": 10,
"grade": "良好",
"items": {
"position": {
"score": 1.6,
"details": {
"atrPct": 1.8803702010968921,
"turnoverUsdM": 126.07457296,
"liquidityPoints": 0.4,
"volatilityPoints": 1.2
}
},
"rrPoints": 1.4,
"stopLevels": {
"symbol": "US.HSIC",
"rr_range": "1:1.0-1:2.5",
"risk_profile": "中等",
"stop_loss_price": 84.2286,
"strength_details": {
"ma_score": 2,
"atr_score": 2.5,
"rsi_score": 1,
"macd_score": 1.5,
"volume_score": 2
},
"market_adjustment": 1,
"risk_reward_ratio": 1.3,
"stop_loss_percent": 3.8,
"take_profit_price": 91.896,
"target_multiplier": 1.9,
"technical_strength": 1.75,
"take_profit_percent": 5
},
"positionPoints": 1.6,
"stopLossPoints": 2.4,
"diversification": {
"score": 2,
"details": {
"method": "sector concentration proxy; no portfolio holdings used",
"sector": "Health Care",
"concentratedSectorPenalty": 0
}
},
"riskRewardRatio": 1.3295254299082457,
"stopLossPercent": 3.7607404021937842,
"diversificationPoints": 2
}
}
}
},
"modelVersion": "cursor_18_27_news_v2_160",
"providerErrors": [
{
"code": "VIX_MISSING",
"symbol": "US.HSIC",
"message": "VIX market context is required for market environment scoring",
"missing": [
"VIX"
],
"provider": "scoring"
}
],
"rankingScoreMax": 160,
"dataCompleteness": {
"complete": false,
"missingFields": [
"VIX"
],
"optionalInputs": [
"institutionalData"
],
"requiredInputs": [
"fundamentals",
"marketContext.VIX",
"marketContext.SPY",
"marketContext.QQQ",
"catalystData",
"sentimentData",
"ATR",
"sector"
],
"optionalInputWarnings": []
},
"technicalIndicators": {
"adx": 92.86,
"atr": {
"atr": 1.6457,
"rule": "ATR / current price; lower volatility scores higher",
"score": 8,
"atr_pct": 1.88
},
"cci": {
"rule": "Cursor_18.24 CCI bands",
"level": "超買或超賣風險",
"score": 2,
"value": -119.41
},
"cmf": {
"rule": "Cursor_18.24 CMF bands",
"level": "派發",
"score": 2,
"value": -0.2072
},
"kdj": {
"d": 29.56,
"j": 9.65,
"k": 22.92,
"rule": "Cursor_18.24 K/D cross",
"score": 0,
"signal": "死叉"
},
"mfi": {
"rule": "Cursor_18.24 MFI bands",
"level": "超賣或超買風險",
"score": 2,
"value": 36.49
},
"obv": {
"rule": "Cursor_18.24 recent_slope vs previous_slope",
"score": 2,
"trend": "資金流出",
"value": 13830477,
"recentSlope": -227362.3,
"previousSlope": 211110
},
"rsi": 41.19,
"sar": {
"rule": "Cursor_18.24 Parabolic SAR",
"score": 4,
"trend": "下降",
"value": 91.4207,
"position": "SAR喺價上",
"distancePct": 4.46,
"previousTrend": "下降"
},
"ma50": 87.8064,
"macd": {
"macd": 0.10594149524966667,
"trend": "中性偏多",
"signal": 0.4664787224630217,
"histogram": -0.360537227213355
},
"vwap": {
"rule": "Cursor_18.24 VWAP 20D consecutive close",
"score": 2,
"value": 89.1254,
"position": "<VWAP",
"consecutiveAbove": 0
},
"volume": {
"rule": "Cursor_18.24 volume ratio",
"level": "有量",
"ratio": 1.61,
"score": 6,
"avgVolume": 894241,
"currentVolume": 1440523
},
"derived": {
"ma20": 89.157,
"ma50": 87.8064,
"prevClose": 88.93,
"avgVolume10": 913342,
"avgVolume20": 894241,
"changePercent": -1.59,
"avgVolumeForScore": 894241
},
"ma_cross": {
"ma20": 89.157,
"ma50": 87.8064,
"rule": "Cursor_18.24 MA20/MA50 cross",
"cross": "接近",
"score": 6,
"prevMa20": 89.257,
"prevMa50": 87.7884,
"spreadPct": 1.54,
"isVolumeBreakout": true
},
"bollinger": {
"lower": 87.2504,
"upper": 91.0636,
"position": "中間"
},
"rsi_short": 29.37,
"macd_short": {
"macd": 0,
"trend": "中性",
"signal": 0,
"histogram": 0
},
"volume_ratio": {
"ratio": 1.61
}
}
}
Raw metrics JSON
{
"close": 87.52,
"volume": 1440523,
"changePercent": -1.59
}
Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.